TG Therapeutics (NASDAQ:TGTX – Get Free Report) released its quarterly earnings data on Wednesday. The biopharmaceutical company reported ($0.07) EPS for the quarter, missing the consensus estimate of ($0.05) by ($0.02), Briefing.com reports. The company had revenue of $63.47 million during the quarter, compared to analyst estimates of $54.60 million. TG Therapeutics had a net […]

Related Keywords

United States , Laurencen Charney , , Jpmorgan Chase Co , Tg Therapeutics Company Profile , Goldman Sachs Group , Tg Therapeutics Inc , Securities Exchange Commission , Get Free Report , Director Laurence , Exchange Commission , Tg Therapeutics , Nasdaq Tgtx , Tgtx , Medical , Earnings ,